Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator
Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator
About this item
Full title
Author / Creator
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Long-term hemodialysis patients with a newly inserted central venous catheter received heparin three times a week or recombinant tissue plasminogen activator (rt-PA) instead of heparin at the midweek session. The use of rt-PA reduced the incidence of catheter malfunction and bacteremia.
Central venous catheters are used for vascular access in th...
Alternative Titles
Full title
Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_847639297
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_847639297
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1011376
